Compare Garmin Ltd. (GRMN) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Garmin Ltd. vs Nuwellis Inc — how do they compare? Garmin Ltd. trades at $311.07 (market cap $59.72B), while Nuwellis Inc trades at $1.41 (market cap $542.80K). The key difference: Garmin Ltd. is far larger — about 110022.1× Nuwellis Inc's market cap, and Garmin Ltd. pays a 1.36% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| GRMN | NUWE | |
|---|---|---|
Market Cap | $59.72B | $542.80K |
Sector | Technology | Technology |
52-Week High | $313.16 | $220.50 |
52-Week Low | $187.10 | $1.42 |
Enterprise Value | $57.23B | -$1.27M |
Dividend Yield | 1.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Garmin (GRMN) trades at $310.22, down 0.94% on the day, yet maintains a bullish technical trend with strong moving averages and support near $308. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $2.81 surpassing the $2.30 estimate, driven by 11% revenue growth. Profitability remains high, with a net margin of 24.47% and ROE of 21.89%, though valuation multiples like P/E of 31.96 appear elevated. Recent news highlights surging fitness segment demand and a raised 2026 outlook.
Garmin's outlook is supported by consistent earnings outperformance and growth in wearable technology, but risks include rich valuations and potential sales deceleration. Analyst consensus is a $318.67 price target with a Hold-heavy rating, suggesting cautious optimism amid near-term strength. The stock's proximity to its 52-week high warrants monitoring for sustainability of momentum.
NUWE trades at $1.41, down 0.7% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with preliminary Q2 2026 revenue up 14% year-over-year, but remains unprofitable with a net income margin of -217.22%. Recent developments include a reverse stock split, new CEO appointment, and expansion of its Aquadex platform into new pediatric markets. Cash flow from operations is negative, though recent financing activities have provided capital.
The outlook is mixed: growth initiatives and analyst support offer potential, but persistent losses and high cash burn pose significant risks. Investors should weigh the company's expansion against its financial sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Garmin Ltd.
Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.
Read more on GRMN →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
